Abdominal Aortic Aneurysm: Men Benefit from Ultrasound Screening
An abdominal aortic aneurysm is a pathological dilation of the main abdominal artery (aorta). Its diameter varies depending on age and sex; an abdominal aorta with a diameter of 3 cm or more is called an AAA. Most AAAs cause no problems (asymptomatic), but the larger the size of AAA, the greater the danger that this large blood vessel will rupture. Ultrasound screening aims to identify, monitor, and treat an AAA before a rupture occurs.
IQWiG's review covered studies comparing one-time screening via ultrasound with a different screening strategy (eg, using a different diagnostic technique) or no screening. The focus of the assessment was on patient-relevant outcomes.
Four randomised controlled trials (RCTs) were included in the assessment: two from the United Kingdom, one from Denmark, and one from Australia. Participants were enrolled between 1988 and 1999. Three studies included only men aged 65 years or older; one of the four studies also included women, but they only comprised 6.8 percent of the study population.
Data on men aged 65 years or older were summarised at different times of analysis (4-5, 10, and 13-15 years after screening) for the outcomes "overall mortality" and "AAA-related mortality." For all of these times, the researchers noticed proof of a benefit of screening in men for both outcomes.
For women, data are only available on overall mortality at one time (4-5 years). However, due to lack of statistically significant differences between the groups investigated, the benefit of screening for AAA in women is not proven. Data on AAA-related mortality are lacking.
In addition, data on the outcomes "frequency of ruptures" and "emergency surgery" show a similar picture: In women, the available data again showed no relevant differences. In men, results differ somewhat depending on the time of analysis. Overall, however, the researchers acknowledge a benefit of ultrasound screening, as AAA ruptures and emergency surgery occur less often.
The review also found that that the frequency of elective surgery increases with screening. According to researchers, this is the specific aim of screening and is therefore to be expected. If an AAA is detected in time and a patient can undergo elective surgery, the chance of survival is considerably higher. In Germany, for example, depending on the type of surgery (endovascular or open), between 1.3 and 3.6 percent of patients die (30-day mortality).
Based on the results of this review, it thus seems meaningful to introduce one-time screening for AAA in men from the age of 65. However, as the IQWiG researchers point out in their report, there are indications that the results are not transferable one-to-one to the current situation in Germany.
Source: Institute for Quality and Efficiency in Health Care
Image credit: Wikipedia Commons
Published on : Sat, 13 Jun 2015
The aneurysm formed in the portion of aorta in the abdomen cavity is known as Abdominal Aortic Aneurysm. SIMS has got specialized treatments for an aortic aneurysm. 4 to 8 percent of people are getting affected by this disease. The normal size of Abdominal Aorta will be 3 and 3.5cms and those which is above it is considered as rupture. The Abdominal aortic aneurysm treatment is done with EVAR stent grafting. It is also called as AAA.
Please login to leave a comment...
The iViz is a lightweight Point Of Care (POC) ultrasound solution, specifically designed for emerging sub-segments where there is need for a highly accessible and mobile solution that is capable throughout key areas of the patient care path. The iViz...
Transform the breast imaging patient experience The SmartCurve system provides a curved compression surface that offers a more comfortable patient experience without compromising image quality, exam time, dose or workflow.1 The SmartCurve system is...
With its customer driven design, amazing usability and freedom of movement, Agfa's DR 100s offers your facility a new force in mobile imaging. Combining a remarkably narrow width and light weight with a powerful generator and imaging processing, it puts...
The SonoSite SII features a new touchscreen user interface with a clinician-driven menu logic that adaptively adjusts to your imaging needs – “what you need, is what you see”. An embedded dual transducer connector allows you to quickly switch between...
Remarkable image quality, right at the point of care. The Trident system revolutionizes breast tissue imaging by incorporating a micro-focused tube, unique specimen image processing algorithms and amorphous selenium direct digital detector. The...